Accendra Health (ACH) Proxy filing summary

Executive summary

• Annual Meeting scheduled for May 14, 2026, to be held virtually at 9:00 a.m. Eastern Time.

• Shareholders of record as of March 18, 2026, are eligible to vote and attend.

• Proxy materials, including the 2026 Proxy Statement and 2025 Annual Report, are available online.

Voting matters and shareholder proposals

• Election of six directors for one-year terms and until successors are elected.

• Ratification of KPMG LLP as independent auditor for the year ending December 31, 2026.

• Advisory vote on executive compensation (say-on-pay).

• Approval of the Amended and Restated 2023 Omnibus Incentive Plan.

• Other business may be transacted as properly brought before the meeting.

Board of directors and corporate governance

• Six nominees listed for election: Mark A. Beck, Gwendolyn M. Bingham, Kenneth Gardner-Smith, Stephen W. Klemash, Teresa L. Kline, Edward A. Pesicka.